Evidence map›Paper›PMID 37496682›Full record

ArticleFrontiers in psychiatry2023

Case report: Impact of hyperthyroidism on psychotic symptoms in schizophrenia comorbid with Graves' disease.

Yukiyoshi Sumi, Sanae Kawahara, Kumiko Fujii, Mayu Yamaji, Kou Nakajima, Tsubasa Nakamura, Osamu Horikawa, Yukihiro Fujita, Yuji Ozeki

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yukiyoshi SumiDepartment of Psychiatry, Shiga University of Medical Science, Otsu, Shiga, Japan.
Sanae KawaharaDepartment of Psychiatry, Shiga University of Medical Science, Otsu, Shiga, Japan.
Kumiko FujiiDepartment of Psychiatry, Shiga University of Medical Science, Otsu, Shiga, Japan.
Mayu YamajiDepartment of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Kou NakajimaDepartment of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Tsubasa NakamuraDepartment of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Osamu HorikawaDepartment of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Yukihiro FujitaDepartment of Diabetology, Endocrinology and Nephrology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Yuji OzekiDepartment of Psychiatry, Shiga University of Medical Science, Otsu, Shiga, Japan.
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Auditory hallucinations are the most common type of hallucinations observed in schizophrenia; however, visual hallucinations are not uncommon. In Graves' disease, depression, hypomania, and psychosis can occur. While the association between Graves' disease and psychosis has been explored, understanding of the specific impact of thyroid dysfunction severity on psychiatric symptom severity is limited. Here, we present a case report of a patient with schizophrenia comorbid with Graves' disease whose psychotic symptoms were impacted by hyperthyroidism. Case: The patient was a 32-year-old Japanese woman who presented with auditory and visual hallucinations, agitation, and pressured speech. The patient was diagnosed with schizophrenia comorbid with Graves' disease and thyroid storm. The patient's psychotic symptoms were found to be associated with fluctuations in thyroid hormone levels, and visual hallucinations were observed only during thyroid storms. Treatment involved dexamethasone, potassium iodide, bisoprolol fumarate, and methimazole for thyrotoxicosis, and a blonanserin transdermal patch, paliperidone, and paliperidone palmitate for psychotic symptoms. The patient's auditory and visual hallucinations improved with antipsychotic treatment and decreased thyroid hormone levels. Conclusion: This case highlights the importance of monitoring thyroid function in patients with schizophrenia, particularly those with comorbid Graves' disease. The correlation between psychiatric symptoms and thyroid hormone levels was demonstrated on an individual level over time, with symptoms worsening as thyroid hormone levels increased. Additionally, our case suggests that abnormally high thyroid hormone levels may trigger visual hallucinations in individuals with schizophrenia. Further studies are needed to elucidate the underlying mechanisms and potential treatment implications of this association.

Indexed as

endocrinologyGraves’ diseaseschizophreniathyroid stormvisual hallucination

Identifiers

PMID37496682
PMCPMC10366534
OpenAlexW4383815839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.